THE USE OF TRANSEXAMIC ACID FOR TOTAL HIP ARTHROPLASTY IN CHRONIC HEMODIALYSIS PATIENTS
https://doi.org/10.24884/0042-4625-2018-177-4-47-51
Abstract
The OBJECTIVE is to determine the possibilities of using tranexamic acid for hip arthroplasty in patients receiving renal replacement therapy. MATERIAL AND METHODS. The material for the study was based on the data of 31 patients with pathology of the hip who underwent primary total hip arthroplasty from 2015 to 2017 at the Clinic of Traumatology and Orthopedics of the «Pavlov First Saint Petersburg State Medical University». RESULTS. The study proves the safety of using tranexamic acid for total hip arthroplasty in chronic hemodialysis patients. CONCLUSION. The use of tranexamic acid for hip arthroplasty in patients receiving renal replacement therapy allows to reduce blood loss. The efficacy was 33 % (p<0.05). It is necessary to strictly adhere to the frequency of introduction of tranexamic acid, and dose adjustment depending on the concentration of blood creatinine.
About the Authors
A. K. Dulaev
Pavlov University
Russian Federation
Russian Federation
St. Petersburg.
A. N. Tsed
Pavlov University
Russian Federation
Russian Federation
St. Petersburg.
N. E. Mushtin
Pavlov University
Russian Federation
Russian Federation
St. Petersburg.
References
1. Ministerstvo zdravoohraneniya i social’nogo razvitiya RF. Available at: www. rosminzdrav.ru (accessed 15.07.2018).
2. Neverov V. A., Salman Raed. Osobennosti gemodializnykh bol’nyh i recipientov allogennnoi pochki, opredelyayushchie trebovaniya k operacii ekhndoprotezirovaniya tazobedrennogo sustava // Vestnik khirurgii im. I. I. Grekova. 2005. № 4. Р. 58–62.
3. Neverov V. A., Klimov A. V., Salman Raed. Otdalennye rezul’taty ekhndoprotezirovaniya tazobedrennogo sustava u bol’nykh s hronicheskoi pochechnoj nedostatochnost’yu // Travmatologiya i ortopediya Rossii. 2006. № 2. P. 214–215.
4. Maïz H. B., Abderrahim E., Zouaghi K. Anemia and end-stage renal disease in the developing world // Artif Organs. 2002. Vol. 26, № 9. P. 760–764.
5. Lasocki S., Krauspe R., von Heymann C. The prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery : a multicentre, observational study // Eur. J. Anaesthesiol. 2015. Vol. 32, № 3. P. 160–167.
6. Shen P. F., Hou W. L., Chen J. B. Effectiveness and safety of tranexamic acid for total knee arthroplasty : a prospective randomized controlled trial // Med. Sci. Monit. 2015. Vol. 21. P. 576–581.
7. Wind T. C., Barfield W. R., Moskal J. T. The effect of tranexamic acid on blood loss and transfusion rate in primary total knee arthroplasty // J. Arthroplasty. 2013. Vol. 28, № 7. P. 1080–1083.
8. Ortmann E., Besser M. W., Klein A. A. Antifibrinolytic agents in current anaesthetic practice // Br. J. Anaesth. 2013. Vol. 111, № 4. P. 549–563.
9. Ker K., Edwards P., Perel P. Effect of tranexamic acid on surgical bleeding : systematic review and cumulative meta-analysis // BMJ. 2012. Vol. 344. P. 3054.
10. Seo J. G., Moon Y. W., Park S. H. The comparative efficacies of intraarticular and IV tranexamic acid for reducing blood loss during total knee arthroplasty // Knee Surg. Sports Traumatol. Arthrosc. 2013. Vol. 21, № 8. P. 1869–1874.
11. Dobesh P. P. Evidence for extended prophylaxis in the setting of orthopedic surgery // Pharmacotherapy. 2004. Vol. 24. Р. 73–81.
12. Molino D., De Lucia D., Gaspare De Santo N. Coagulation disorders in uremia // Semin Nephrol. 2006. Vol. 26. P. 46–51.
13. Parikh A. M., Spencer F. A., Lessard D. Venous thromboembolism in patients with reduced estimated GFR : a populationbased perspective // Am. J. Kidney Dis. 2011. Vol. 58. P. 746–755.
14. Casserly L. F. Thrombosis in end-stage renal disease // Semin Dial. 2003. Vol. 16. P. 245–256.
15. Serna G. Fibrinogen : a new major risk factor for cardiovascular disease. A review of the literature // J. Fam. Pract. 1994. Vol. 39. P. 468–477.
16. Tay K. H. What ‘drives’ the link between the renin-angiotensin-aldosterone system and the prothrombotic state in hypertension? // Am. J. Hypertens. 2008. Vol. 21. P. 1278–1279.
17. Treatment of the bleeding tendency in uremia with cryoprecipitate / P. A. Janson, S. J. Jubelirer, M. J. Weinstein, D. Deykin // N. Engl. J. Med. 1980. Vol. 303. P. 1318–1322.
18. Mannucci P. M., Remuzzi G., Pusineri F. et al. Deamino-8-d-arginine vasopressin shortens the bleeding time in uremia // N. Engl. J. Med. 1983. Vol. 308. P. 8–12.
19. Sloand J. A. Beneficial effect of low-dose transdermal estrogen on bleeding time and clinical bleeding in uremia // Am. J. Kidney Dis. 1995. Vol. 26. P. 22–26.
20. Roberts H. R., Monroe D. M., White G. C. The use of recombinant factor VIIa in the treatment of bleeding disorders // Blood . 2004. Vol. 104. P. 3858–3864.
21. Tranexamic Acid-Use in Orthopedic Surgery. Washington, DC: Pharmacy Benefits Management Services, Medical Advisory Panel and VISN Pharmacist Executives, Veterans Health Administration, Department of Veterans Affairs. October 2014. URL: https://vaww.cmopnational.va.gov/cmop/PBM/Clinical%20Guidance/Abbreviated%20Reviews/TRANEXAMIC%20ACID-Use%20in%20Orthopedic%20Surgery.docx (дата обращения 18.07.2018).
22. Tranexamic acid for the prevention and management of orthopedic surgical hemorrhage: current evidence / Kim Christopher, Sam Si-Hyeong Park, J. Roderick Davey // Journal of blood medicine. 2015. Vol. 6. P. 239–244.
23. Tranexamic acid: Drug information Copyright 19782015 Lexicomp, Inc. URL: http://www.theapms.com/sitePagesContent/drugs-docs/TXA.pdf (дата обращения 18.07.2018).
24. Mišo Šabovic, Janez Lavre, Bojan Vujkovac. Nephrol Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients // Dial Transplant. 2003. Vol. 18. P. 1388–1391.
25. Australian Public Assessment Report for Tranexamic acid Proprietary Product Name: Cyklokapron Sponsor: Pfizer Australia Pty Ltd. URL: https://www.tga.gov.au/sites/default/files/auspar-cyklokapron.pdf (дата обращения 18.07.2018).
Review
For citations:
Dulaev A.K., Tsed A.N., Mushtin N.E. THE USE OF TRANSEXAMIC ACID FOR TOTAL HIP ARTHROPLASTY IN CHRONIC HEMODIALYSIS PATIENTS. Grekov's Bulletin of Surgery. 2018;177(4):47-51. (In Russ.) https://doi.org/10.24884/0042-4625-2018-177-4-47-51
Views:
826
Email this article 